Shein is re-entering the Indian market after a 2020 ban, partnering with Reliance Retail for a test launch. The company aims to challenge local fast-fashion brands and capitalize on India's growing ...
H.B. Fuller revises 2024 guidance, projecting lower revenue and EBITDA due to delayed orders and weak demand in key sectors. Rising raw material costs and price increase delays impact H.B. Fuller ...
Bhageria Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2024 ,inter alia, to consider and approve Bhageria Industries Limited has ...
Hindustan Unilever Ltd. has decided to discontinue the agreement with Jagatjit Industries Ltd. for the manufacturing and supply of malted milk food products, viz. Boost and Horlicks, at the ...
Nakoda Group of Industries Ltd soared 10.28% to Rs 47.09 at 12:01 IST. The stock was the biggest gainer in the BSE's 'B' group. On the BSE, 1.09 lakh shares were traded on the counter so far as ...
China industries to watch in 2025 review starts from the country’s strategic focus on green energy, electric vehicles, AI, healthcare, and advanced manufacturing, all presenting lucrative ...
Rate this FBO in each of the five categories below, from 1 star (worst) to 5 stars (best), then click the Add Ratings button ...
Dan Priest is the new Chief AI Officer at PwC, one of the world’s largest consulting firms, where he works with companies across industries as they adopt this burgeoning technology both into their day ...
Reliance Industries, through its subsidiary RSBVL, has acquired the oncology-focused platform Karkinos for Rs 375 crore. Karkinos provides technology-driven cancer care solutions and aims to offer ...
Elon Musk has become embroiled in a bitter row with some of Donald Trump’s right-wing supporters (Picture: AP) The billionaire – who has been selected to head up the new Department of ...
But as the International Monetary Fund signalled in its latest World Economic Outlook: "Brace for uncertain times". Sign up here.
“Scorpion is dedicated to expanding the reach of precision medicine to as many patients as quickly as possible. Our updated analyses presented at SABCS show STX-478’s low dose modification ...